Back
Halozyme Therapeutics Vs. Edgewise Therapeutics Industry Stock Comparison
Sell
30
HALO
Halozyme Therapeutics
Last Price:
52.16
Seasonality Move:
20.13%
Buy
72
EWTX
Edgewise Therapeutics
Last Price:
30.01
Seasonality Move:
13.73%
Sell
30
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $50.65. The Score for HALO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $30.33. The Score for EWTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $50.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $30.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.4 | Sell |
Relative Strength Index (14 RSI): | 30.8 | Sell |
Chaikin Money Flow: | -1825954 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.62 - 61.32) | Sell |
Bollinger Bands (100): | (49 - 60.08) | Sell |
EWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.47 | Buy |
Relative Strength Index (14 RSI): | 71.49 | Buy |
Chaikin Money Flow: | 1376532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.65 - 28.39) | Buy |
Bollinger Bands (100): | (16.13 - 23.39) | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.28 | Sell |
20-day SMA: | 58.18 | Sell |
50-day SMA: | 58.64 | Sell |
200-day SMA: | 46.49 | Buy |
8-day EMA: | 55.36 | Sell |
20-day EMA: | 57.29 | Sell |
50-day EMA: | 57.37 | Sell |
200-day EMA: | 49.67 | Buy |
EWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.85 | Buy |
20-day SMA: | 25.06 | Buy |
50-day SMA: | 20.75 | Buy |
200-day SMA: | 17.95 | Buy |
8-day EMA: | 27.95 | Buy |
20-day EMA: | 25.53 | Buy |
50-day EMA: | 22.44 | Buy |
200-day EMA: | 17.77 | Buy |
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.79 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Halozyme Therapeutics Technical Analysis
Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Edgewise Therapeutics Technical Analysis
Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |